Article
Immune phenotype and RAS/BRAF status predict outcomes after lung metastasectomy for colorectal cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Oct 2026
Martin-Cullell Berta, Piedra Aida, Virgili Anna Cristina, Fumagalli Caterina, Cerdà Paula, Mirallas Oriol, Sanz Judit, Restrepo Sara, Trujillo Juan Carlos, Martínez Elisabeth, Belda-Sanchís Jose, Szafranska Justyna, Páez David
Abstract excerpt
PURPOSE: Colorectal cancer (CRC) presents a marked biological heterogeneity, and the lung is a frequent site of metastatic spread. Although pulmonary metastasectomy can lead to a long-term survival, recurrence rates remain high and prognostic markers are lacking. This study evaluated the prognostic value of clinical, molecular, and histopathological features in CRC patients undergoing lung metastasectomy....
Read the complete abstract on PubMedTopics
- Humans
- Colorectal Neoplasms
- Proto-Oncogene Proteins B-raf
- Lung Neoplasms
